MF
FOLD icon

Magnetar Financial’s Amicus Therapeutics FOLD Stock Holding History

Magnetar Financial’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,986,058
Closed -$57.6M – 1272
2026
Q1 		$57.6M Buy
3,986,058
+18,143
+0.5% +$260K 0.59% 21
2025
Q4 		$56.5M Buy
+3,967,915
New +$39M 0.55% 23
2025
Q2 		– Sell
-49,393
Closed -$403K – 971
2025
Q1 		$403K Buy
49,393
+29,280
+146% +$271K 0.01% 509
2024
Q4 		$189K Sell
20,113
-1,964
-9% -$20.4K ﹤0.01% 557
2024
Q3 		$236K Buy
+22,077
New +$240K 0.01% 444
2021
Q3 		– Sell
-18,850
Closed -$182K – 1378
2021
Q2 		$182K Sell
18,850
-11,155
-37% -$109K ﹤0.01% 1116
2021
Q1 		$296K Buy
+30,005
New +$464K ﹤0.01% 928

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Magnetar Financial's FOLD Position: Q2 2026 in Review

Magnetar Financial sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 3,986,058 shares — an estimated $57.6M sold.

Magnetar Financial first reported a position in FOLD in Q1 2021 and held it in 7 quarters. The position peaked at $57.6M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Magnetar Financial reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Magnetar Financial sold 3,986,058 Amicus Therapeutics shares in Q2 2026, an estimated $57.6M.
  • Magnetar Financial first reported a position in Amicus Therapeutics in Q1 2021 and held it in 7 quarters.
  • Magnetar Financial's Amicus Therapeutics position peaked at $57.6M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.